0001739410false00017394102024-05-152024-05-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________________________________
FORM 8-K
______________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 2024
______________________________________________________
RALLYBIO CORPORATION
(Exact name of Registrant as Specified in Its Charter)
______________________________________________________
Delaware001-4069385-1083789
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)(IRS Employer
Identification No.)
234 Church Street, Suite 1020 New Haven, Connecticut
06510
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: 203 859-3820
(Former Name or Former Address, if Changed Since Last Report)
______________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per shareRLYBNASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.07. Submission of Matters to a Vote of Security Holders.
Rallybio Corporation (Rallybio) held its annual meeting of shareholders on May 15, 2024.
The results of the matters voted on by the shareholders are set forth below.

1. The following nominees were elected to the Board of Directors as Class III directors for terms expiring at the 2027 annual meeting of shareholders.

ForAgainstAbstentions/Broker Non-Votes
Wendy K. Chung19,582,0517,206,2014,647,512
Robert Hopfner19,765,7367,022,5174,647,511
Ronald Hunt19,758,5217,029,7254,647,518
Hui Liu26,568,854219,3984,647,512


2. The shareholders ratified the appointment of Deloitte and Touche LLP as the independent registered public accounting firm for Rallybio for the fiscal year ending December 31, 2024.

ForAgainstAbstentions/Broker Non-Votes
31,396,23632,3557,173






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
RALLYBIO CORPORATION
Date:May 21, 2024By:/s/ Jonathan I. Lieber
Jonathan I. Lieber
Chief Financial Officer and Treasurer

v3.24.1.1.u2
Cover
May 15, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 15, 2024
Entity Registrant Name RALLYBIO CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-40693
Entity Tax Identification Number 85-1083789
Entity Address, Address Line One 234 Church Street,
Entity Address, Address Line Two Suite 1020
Entity Address, City or Town New Haven,
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06510
City Area Code 203
Local Phone Number 859-3820
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol RLYB
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Central Index Key 0001739410
Amendment Flag false
Entity Ex Transition Period false

Rallybio (NASDAQ:RLYB)
過去 株価チャート
から 5 2024 まで 6 2024 Rallybioのチャートをもっと見るにはこちらをクリック
Rallybio (NASDAQ:RLYB)
過去 株価チャート
から 6 2023 まで 6 2024 Rallybioのチャートをもっと見るにはこちらをクリック